Free Trial

Innoviva (INVA) Earnings Date, Estimates & Call Transcripts

Innoviva logo
$17.79 -0.05 (-0.28%)
(As of 05:26 PM ET)

Innoviva Latest Earnings Summary

Actual EPS
(Nov. 6)
$0.02 Missed By -$0.25
Consensus EPS
(Nov. 6)
$0.27

Innoviva announced Q3 2024 earnings on November 6, 2024, reporting an EPS of $0.02, which missed the consensus estimate of $0.27 by $0.25. Quarterly revenue was reported to be $89.51 million. With a trailing EPS of $0.69 and a P/E Ratio of 25.78,

Get Innoviva Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Innoviva and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

INVA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INVA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Innoviva Analyst EPS Estimates

Current Year EPS Consensus Estimate:$0.33 EPS

Innoviva Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/6/2024-$0.27$0.02 -$0.25$0.02-$89.51M
7/31/2024Q2 2024-$0.68+$0.68$1.91-$99.90M
5/8/2024Q1 2024-$0.46+$0.46$0.46-$77.50M
2/29/2024Q4 2023-$0.76+$0.76$0.76-$85.84M
11/1/2023Q3 2023-$0.98+$0.98$0.98-$67.26M
8/2/2023Q2 2023-$0.08+$0.08$0.14-$80.99M
5/9/2023Q1 2023-$0.42+$0.42$0.42$68.04M$76.37M
2/28/2023Q4 2022$0.41$0.25 -$0.16$1.48$98.31M$65.80M


This page (NASDAQ:INVA) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners